Scott Fosko, MD
MOHS-Micrographic Surgery · Gainesville, FLNPI 1598782476
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $70,000 of the $99,973 with a category attached, or 70.0%. Genentech USA, Inc. accounts for 87.5% of it on its own, with 2 other manufacturers making up the rest. Among mohs-micrographic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $1960.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$87K
- LEO Pharma AS$12K
- Sanofi$82
Across 2 payments — averaging $2625.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$5K
- F. Hoffmann-la Roche AG$51
What the payments were for
- Consulting fees$23,89524%
- Speaking & faculty fees$70,00070%
- Travel & lodging$4,9735%
- Food & beverage$1,1051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 45 | $87,497 |
| LEO Pharma AS | 5 | $12,395 |
| Sanofi | 1 | $82 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erivedge$75,535
How this compares
$99,973 in reported general payments places this provider in the 95th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 22 | $210 |
| Cephalexin | 17 | $115 |
| Mupirocin | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Gainesville
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
- Kenneth WallaceOcala$26K
- Lilia CorreaTampa$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.